ERBB2 and breast cancer: Figure 4 shows there was a negative significant (p < 0.05) correlation between ESR1 expression and KLK7 levels in all BRCA and BRCA-LumA cancer patients as well as in NEDD9 in BRCA-Her2 breast cancer patients.